Update on Nanobacteria
The Nanobacteria Link
to Heart Disease and Cancer
Nanoparticles are implicated in the harmful calcification that’s common to many illnesses. A simple treatment is now reversing the symptoms, especially in heart disease, so why aren’t the health authorities telling patients and doctors about it?
by Douglas Mulhall © May–July 2005
Millions of seriously ill patients are unaware that heart disease is being measurably reversed with an approach pioneered by researchers at the National Aeronautics and Space Administration (NASA) and in Finland, aided by Mayo Clinic and Washington Hospital Center findings. This approach is now prescribed by hundreds of doctors for thousands of patients. A similar approach has been developed with prostate disease at the renowned Cleveland Clinic in Florida. According to doctors, both approaches are practical options for those whose other medicines and surgery have failed. So why aren’t other desperately ill patients whose treatments don’t work being told about it?
In July 2004, the medical journal Pathophysiology published a peer-reviewed research paper with the innocuous title “Calcification in coronary artery disease can be reversed by EDTA–tetracycline long-term chemotherapy”.1 In plain terms, it meant that hardening of the arteries was being reversed. Not only were rock-hard calcium deposits being reduced, but chest pains were being resolved in most patients and bad cholesterol levels were being cut beyond what other medicines had achieved. The findings were important for patients whose other drugs and surgery weren’t working, i.e., the “cardiac cripples”, whose numbers are in the millions and whose doctors have told them there is nothing more to be done. They were the ones who responded most favourably to the new approach.
Then, in February 2005, a paper published in the prestigious Journal of Urology by researchers from the Cleveland Clinic, one of the leading urology hospitals in America, reported “significant improvement” in chronic prostatitis—a growing problem for millions of men—again, where other approaches had failed.
The studies, although otherwise separate, had a compelling link. They used a cocktail of well-known, inexpensive medicines that have been around for half a century but were never before used in this combination. Both reports urged more studies to confirm their conclusions, and emphasised that not every patient experienced a reversal; only a majority did. Nonetheless, the results were encouraging. Chronic diseases that had befuddled modern medicine were being reversed.
To put a human face on this, take the case reported by Dr Manjit Bajwa of McLean, Virginia, who did not participate in the clinical studies but whose experience with one patient paralleled study results. Dr Bajwa reported in a testimonial of 5 May 2005:
“Two years ago I had a patient with severe coronary artery disease with a 75–85% blockage in left coronary and two other arteries. Open heart surgery was recommended as stents could not be put in. The patient was told he would probably die within two weeks if surgery was not performed.
“He declined surgery and instead chose chelation. [Author’s note: chelation in this case is an intravenous form of heavy metal removal.] After twenty-five treatments of chelation, his angina worsened [author’s emphasis]. With [his] heart calcium score of 2600, I started the nanobacteria protocol. Within two to three weeks his angina abated. He was able to return to all his normal activities and exercises in two months.
“Nanobacteria protocol helped this patient measurably, when other treatments had failed. I am quite impressed with his results. With heart calcium scores of 750 or more, nothing else seems to work.”
I’ve reported on nanobacteria previously. Frequency sets should always be used in combination with oral or IV chelation therapy. In addition, nanobacteria reinfection is common so periodic elimination is required.
The previous frequency reported had some Lyme frequencies, particularly in the 500-700khz range. This is because over 80% of the people I test have at least a light Lyme infection. As I now have a comprehensive set of six different programs for use in eliminating Lyme organisms, I have removed Lyme frequencies from the nanobacteria set. It should be noted that many humans or animals with a heavy nanobacteria infection will have a concurrent Lyme infection that needs to be addressed.
Nanobacteria frequencies are regularly updated and now available to Frequency Foundation subscribers. See link on side of page to sign up.